AusCann (ASX:AC8) up more than 65pc after completing testing of hard-shell capsules

• Medicinal cannabis company AusCann Group (AC8) is up more than 65 per cent today after completing manufacturing and testing of its hard-shall capsules
• Once tested, the capsules were found to have met all applicable criteria set out by the Australian Therapeutic Goods Administration (TGA)
• These capsules are a unique presentation for cannabinoid medicines and a clinical evaluation will provide the best dose selection

Click to view full article